Jennison Associates LLC Sarepta Therapeutics, Inc. Transaction History

Jennison Associates LLC

$162 Billion
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	BUY	$102.5 - $123.59 $117,670 - $141,881	1,148 Added 0.84%	138,388 $16.8 Million
Q2 2023 Aug 03, 2023	BUY	$106.4 - $157.19 $1.81 Million - $2.67 Million	16,979 Added 14.12%	137,240 $15.7 Million
Q1 2023 Apr 26, 2023	BUY	$117.53 - $155.99 $14.1 Million - $18.8 Million	120,261 New	120,261 $16.6 Million
Q1 2022 May 11, 2022	SELL	$63.15 - $90.42 $19.2 Million - $27.6 Million	-304,735 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$77.28 - $99.42 $19.3 Million - $24.9 Million	250,274 Added 459.55%	304,735 $27.4 Million
Q3 2021 Nov 09, 2021	SELL	$65.97 - $92.48 $505,857 - $709,136	-7,668 Reduced 12.34%	54,461 $5.04 Million
Q2 2021 Aug 12, 2021	SELL	$69.38 - $86.75 $277 - $347	-4 Reduced 0.01%	62,129 $4.83 Million
Q1 2021 May 11, 2021	SELL	$72.25 - $168.95 $171 Million - $400 Million	-2,365,759 Reduced 97.44%	62,133 $4.63 Million
Q4 2020 Feb 05, 2021	SELL	$125.56 - $178.74 $22.2 Million - $31.7 Million	-177,180 Reduced 6.8%	2,427,892 $414 Million
Q3 2020 Nov 04, 2020	BUY	$127.12 - $172.34 $257 Million - $348 Million	2,021,091 Added 346.09%	2,605,072 $366 Million
Q2 2020 Aug 06, 2020	SELL	$93.0 - $171.7 $17.9 Million - $33 Million	-191,939 Reduced 24.74%	583,981 $93.6 Million
Q1 2020 May 06, 2020	BUY	$82.38 - $131.64 $486,783 - $777,860	5,909 Added 0.77%	775,920 $75.9 Million
Q4 2019 Feb 07, 2020	SELL	$76.53 - $135.58 $25.2 Million - $44.7 Million	-329,682 Reduced 29.98%	770,011 $99.4 Million
Q3 2019 Nov 08, 2019	BUY	$72.81 - $156.91 $7.24 Million - $15.6 Million	99,394 Added 9.94%	1,099,693 $82.8 Million
Q2 2019 Aug 06, 2019	SELL	$112.21 - $151.95 $805,667 - $1.09 Million	-7,180 Reduced 0.71%	1,000,299 $0
Q1 2019 May 10, 2019	SELL	$106.67 - $151.68 $1.6 Million - $2.28 Million	-15,036 Reduced 1.47%	1,007,479 $120 Million
Q4 2018 Feb 06, 2019	SELL	$97.32 - $148.76 $19.2 Million - $29.3 Million	-196,988 Reduced 16.15%	1,022,515 $112 Million
Q3 2018 Nov 08, 2018	BUY	$115.31 - $161.51 $646,197 - $905,102	5,604 Added 0.46%	1,219,503 $197 Million
Q2 2018 Aug 02, 2018	SELL	$71.74 - $153.69 $8.11 Million - $17.4 Million	-113,104 Reduced 8.52%	1,213,899 $160 Million
Q1 2018 Apr 20, 2018	BUY	$54.02 - $82.27 $9.55 Million - $14.5 Million	176,793 Added 15.37%	1,327,003 $98.3 Million
Q4 2017 Jan 25, 2018	BUY	$47.64 - $56.75 $302,847 - $360,759	6,357 Added 0.56%	1,150,210 $64 Million
Q3 2017 Nov 03, 2017	BUY	$35.73 - $47.15 $40.9 Million - $53.9 Million	1,143,853	1,143,853 $51.9 Million

Others Institutions Holding SRPT

# of Institutions

535

Shares Held

87.4M

Call Options Held

1.55M

Put Options Held

1.35M

Black Rock Inc. New York, NY

10.3M
Shares

$1.05 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

9.09M
Shares

$921 Million
0.02% of portfolio
Capital International Investors Los Angeles, CA

8.7M
Shares

$881 Million
0.21% of portfolio
Janus Henderson Group PLC London, X0

4.33M
Shares

$439 Million
0.28% of portfolio
State Street Corp Boston, MA

4.07M
Shares

$412 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $8.88B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Account